A few days ago, Entera Bio (NASDAQ: ENTX) shares shot up in value from just over $4 to over $8. This article explores what the company is, why this surge has occurred, and where to buy shares.
Biotechnology companies often attract a lot of attention from investors because of their high risks and lofty rewards. The same is true of Entera Bio, which has surged in value following positive test results.
This article tells you the key things you need to know before you invest in Entera Bio, including what the company does and what its investment prospects are. Let’s get started with the best places to buy Entera Bio shares.
Where to buy Entera Bio stock online
If you want to invest in ENTX shares quickly, easily and with low fees, sign up to one of the reliable stockbrokers below and get started. Our team of analysts have singled them out as two of the best options available to you:
eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.
Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.
What is Entera Bio?
Founded on June 1st, 2010 and headquartered in Jerusalem, Israel, Entera Bio Ltd. is a clinical-stage biopharmaceutical company. Its primary target is to commercialise orally delivered large molecule therapeutics, such as an oral formulation of parathyroid hormone.
Following positive topline results in the 6-month Phase-2 clinical trial of its EB613 treatment, which was a dose-ranging, placebo-controlled study in postmenopausal female subjects with osteoporosis, speculation has grown that ENTX could be onto a winner.
Should you buy ENTX stock?
If you want to invest in a high-risk stock with the potential for huge rewards, then it could be a good buy. Just make sure you conduct your own research and recognise that biopharmaceutical stocks carry increased risks because each product must go through a lengthy testing and approval process before achieving commercialisation.
ENTX price target
Our ENTX price prediction is as follows: $12 in the next 6 months, which is an 85% target upside.